Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07815067
PHASE1

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

Sponsor: Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

The purpose of this clinical study is to test how taking zenagamtide tablets with different meal/water variations affects how much zenagamtide enters the bloodstream in people who have overweight or obesity. All participants will get zenagamtide.

Official title: Investigating the Effect of Post-dose Meal Timings and Water Volume at Dosing on the Pharmacokinetic Properties of Oral Zenagamtide in Participants With Overweight or Obesity

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

320

Start Date

2026-09-07

Completion Date

2028-06-12

Last Updated

2026-09-11

Healthy Volunteers

No

Interventions

DRUG

Zenagamtide injection

Zenagamtide will be administered to one of the body parts: thigh, abdomen or upper arm

DRUG

Zenagamtide tablet

Zenagamtide tablet will be taken in the morning in fasted state.

Locations (1)

Charité - Campus Charité Mitte - Charité Research Organisation GmbH

Berlin, Germany